GENZYME CORP Deferred Tax Assets, Net of Valuation Allowance, Current
GENZYME CORP had Deferred Tax Assets, Net of Valuation Allowance, Current of $220.85 million as of 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2011-03-01
- 2010-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $220.85M.
- 2010-09-30: Deferred Tax Assets, Net of Valuation Allowance, Current $184.66M.
- 2010-06-30: Deferred Tax Assets, Net of Valuation Allowance, Current $183.70M.
- 2010-03-31: Deferred Tax Assets, Net of Valuation Allowance, Current $181.32M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2010-12-31 | $220.85M 10-K · filed 2011-03-01 |
| 2010-09-30 | $184.66M 10-Q · filed 2010-11-09 |
| 2010-06-30 | $183.70M 10-Q/A · filed 2010-09-07 |
| 2010-03-31 | $181.32M 10-Q/A · filed 2010-05-11 |
| 2009-12-31 | $178.43M 10-K · filed 2011-03-01 |
| 2009-09-30 | $188.33M 10-Q · filed 2009-11-02 |
| 2009-06-30 | $187.95M 10-Q/A · filed 2009-09-04 |
| 2008-12-31 | $188.10M 8-K · filed 2010-06-14 |